EW vs STE — Key Metrics

Metric EW (EDWARDS LIFESCIENCES CORP) STE (STERIS PLC)
Price105.23259.57
Market Cap60.51 Billion25.21 Billion
P/E (TTM)59.4530.68
P/B (Quarterly)5.2613.4
P/S (TTM)9.074.09
Net Profit Margin (TTM)15.313.4
Gross Margin (TTM)78.044.6
ROE (TTM)9.711.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

EDWARDS LIFESCIENCES CORP
vs
 
STERIS PLC
 
EDWARDS LIFESCIENCES CORP
vs
 
STERIS PLC
Performance Comparison
AI Model Recommendation
EW · EDWARDS LIFESCIENCES CORP
hmmm...
STE · STERIS PLC

Greatly Underperform

-92
UnderperformOutperform
Recommendation Summary

Stock EW is projected to underperform the market, stock STE is projected to greatly underperform the market. Upfront Recommendation: EW.

Financial Metrics
Prices delayed ~15 min
EW Metrics STE
$105.23 Price $259.57
— Market Capitalization —
59.45 Price to Earnings Ratio 30.68
9.07 Price to Sales 4.09
42.49 Price to FCF Ratio 26.6
11.62 Price to Gross Profit 9.17
55.45 Price to R&D 212.89
8.35 Price to Current Assets 10.17

EW vs STE at a glance

Edwards Lifesciences Corp (EW) and Steris PLC (STE) are both Medical Devices companies in the Healthcare sector. EW is the larger, at $60.5 billion in market value against $25.2 billion for STE, about 2.4 times the size.

On trailing-twelve-month figures, EW trades at 59.5 times trailing earnings and STE at 30.7; net profit margins are 15.3% and 13.4%.

The Upfront Investment model currently rates EW Underperform and STE Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.